Completed OBSERVATIONAL NCT04455737

Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision (RLF)

Sponsor: Walter Brunner

Interventions injection of indigo carmine

Updated 5 times since 2020 Last updated: Aug 3, 2021 Started: Oct 31, 2013 Primary completion: Dec 31, 2019 Completion: Jun 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04455737, this observational or N/A phase trial focuses on Rectal Neoplasms and remains completed. Sponsored by Walter Brunner, it has been updated 5 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Sep 2021 [monthly]

Completed
Aug 2020 — Jan 2021 [monthly]

Completed

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Walter Brunner

Data source: Cantonal Hospital of St. Gallen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rorschach, Switzerland